Abstract:
PROBLEM TO BE SOLVED: To prevent or ameliorate cancer by compounding daily takable food with a composition with anticancer activity containing ingredients extracted from Cordyceps and/or its mycelia-cultured solution, or by compounding drugs with such a composition containing the ingredients.SOLUTION: Cordyceps and/or its mycelia-cultured solution is subjected to, according as needed, hot water extraction; subsequently, the Cordyceps and/or its mycelia-cultured solution, or a solution obtained by subjecting the Cordyceps and/or its mycelia-cultured solution to hot-water extraction, is subjected to hydrous alcohol extraction; subsequently, the resulting solution obtained by the hydrous alcohol extraction is subjected to reverse-phase column chromatography under predetermined conditions to make a crude fractionation to obtain fractions. Thereafter, a composition with anticancer activity containing ingredients contained in fractions with retention times of 4.4-5.5 min (fractions F2 to 4) among the fractions, is obtained. Using the composition, cancer can be prevented or ameliorated.
Abstract:
PROBLEM TO BE SOLVED: To prevent or improve gout and hyperuricemia as well as to prevent prostate hypertrophy and male alopecia to improve the QOL (quality of life) of users by compounding an extract and/or dried powder of Kaempferia parviflora into foods and drinks or pharmaceutical products which can be daily ingested, or by compounding into cosmetics to be used, on the basis of the discovery that an extract and/or dried powder of Kaempferia parviflora has a xanthine oxidase inhibition effect and a 5α-reductase inhibition effect.SOLUTION: The xanthine oxidase inhibitor contains an extract and/or dried powder of Kaempferia parviflora.
Abstract:
PROBLEM TO BE SOLVED: To prevent prostatic hyperplasia and male-pattern alopecia to thereby improve QOL based on a finding that 3,5,7,3',4'-pentamethoxyflavone and 5,7,3',4'-tetramethoxyflavone have 5α-reductase inhibiting action, by compounding the compounds to regularly takable foods, drinks or pharmaceuticals or to cosmetics.SOLUTION: There is provided a 5α-reductase inhibitor containing 5,7,3',4'-tetramethoxyflavone and/or 3,5,7,3',4'-pentamethoxyflavone as active components.
Abstract:
PROBLEM TO BE SOLVED: To provide a hemorheology improving agent useful for prevention/treatment of thrombosis and various diseases relating to thrombosis such as peripheral arteriovenous thrombosis, pulmonary embolism, myocardial infarction, coronary artery occlusion, cerebrovascular occlusion, and retinal arteriovenous thrombosis; and to provide food and drink and pharmaceutical compositions including the hemorheology improving agent.SOLUTION: A hemorheology improving agent includes 3,5,7,3',4'-pentamethoxy flavone represented by formula as an active ingredient. Food and drink and pharmaceutical compositions including the hemorheology improving agent are also provided.